Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Revision: 37, Status: Authorised
Xeljanz is a medicine used to treat: Xeljanz contains the active substance tofacitinib.
Informasi Obat dan Panduan Pengobatan
Informasi obat, indikasi, dosis, dan keamanan yang terkait dengan produk yang tersedia saat ini.
LEQSELVI (deuruxolitinib phosphate) tablet, film coated [Sun Pharmaceutical Industries, Inc.]
Packager: Sun Pharmaceutical Industries, Inc.
OLUMIANT (baricitinib) tablet, film coated [Eli Lilly and Company]
Boxed Warnings, Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary View Labeling Archives, RxNorm, G…
